Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease

Gastroenterology

Volumn 109, Issue 3, 1995, Pages 681-691

  El Omar, Emad M ^a   Penman, Ian D ^a   Ardill, Joy E S ^b   Chittajallu, Ravi S ^a   Howie, Catherine ^a   McColl, Kenneth E L ^a  

^a WESTERN INFIRMARY   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GASTRIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DUODENUM ULCER; FEMALE; GASTRIN RELEASE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; MALE; PRIORITY JOURNAL; STOMACH ACID SECRETION; TREATMENT OUTCOME;

EID: 0029149571     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/0016-5085(95)90374-7     Document Type: Article

References (54)

1. CAMPYLOBACTER PYLORI AND RECURRENCE OF DUODENAL ULCERS— A 12-MONTH FOLLOW-UP STUDY
2. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori
3. Cure of duodenal ulcer associated with eradication of Helicobacter pylori
4. Effect of ranitidine and amoxycillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer
5. Plasma gastrin, daytime intragastric pH, and nocturnal acid output before and at 1 and 7 months after eradication of Helicobacter pylori in duodenal ulcer subjects
6. Amoxycillin plus tinidazole for Campylobacter pylori gastritis in children: assessment by serum IgG antibody, pepsinogen I, and gastrin levels
7. Eradication of Helicobacter pylori abolishes 24-hour hypergastrinaemia: a prospective study in healthy subjects
8. Antral Helicobacter pylori, hypergastrinaemia and duodenal ulcers: effect of eradicating the organism
9. Ablation of exaggerated meal-stimulated gastrin release in duodenal ulcer patients after clearance of Helicobacter (Campylobacter) pylori infection
10. Helicobacter pylori—related hypergastrinaemia is due to a selective increase in gastrin G17
11. Effect of Helicobacter pylori on Parietal Cell Sensitivity to Pentagastrin in Duodenal Ulcer Subjects
12. Acid secretion and sensitivity to gastrin in patients with duodenal ulcer: effect of eradication of Helicobacter pylori
13. Gastrin is a major mediator of the gastric phase of acid secretion in dogs: proof by monoclonal antibody neutralisation
14. Bombesin stimulates human gastric function by gastrin-dependent and independent mechanisms
15. Origin of gastrin liberated by gastrin releasing peptide in man
16. Bombesin and G-17 dose responses in duodenal ulcer and controls
17. The role of vagal integrity in gastrin releasing peptide stimulated gastroenteropancreatic hormone release and gastric acid secretion
18. The effect of gastrin releasing peptide on porcine pancreaticobiliary bicarbonate secretion is mediated by secretin
19. Eradicating Helicobacter pylori infection lowers gastrin-mediated acid secretion by two-thirds in patients with duodenal ulcer
20. Detection of Helicobacter pylori infection of the gastric mucosa by measurement of gastric aspirate ammonium and urea concentrations
21. Positioning of subject and of nasogastric tube during a gastric secretion study
22. The GRP test: a new clinical test of acid secretion-reproducibility data
23. Pathogenesis and pathophysiology of duodenal ulcer
24. Detailed comparison of basal and food-stimulated gastric acid secretion rates and serum gastrin concentrations in duodenal ulcer patients and normal subjects
25. Total 24-hour gastric acid secretion in patients with duodenal ulcer
26. The use of pentagastrin in a test of gastric acid secretion
27. Treatment of Campylobacter pylori does not alter gastric acid secretion
28. Gastrin and gastric acid output 1 year after eradication of helicobacter pylori (HP) in duodenal ulcer patients
29. Effect of curative gastrinoma resection on gastric secretory function and antisecretory drug requirement in the Zollinger-Ellison syndrome
30. Duodenal ulcer with unexplained marked basal gastric acid hypersecretion
31. Effect of sham feeding on gastric acid secretion in healthy subjects and duodenal ulcer patients
32. Inhibition of bombesin-stimulated gastric acid secretion by secretin, glucagon and caerulein in patients with duodenal ulcer
33. Effect of bombesin-stimulated gastrin on gastric acid secretion in man
34. Role of endogenous secretin in acid-induced inhibition of human gastric function
35. Prostaglandins mediate the inhibition of human gastric acid secretion produced by intraduodenal acidification and secretin but not intraduodenal fat
36. Intestinal inhibitors of acid secretion: comparative potencies and effects on inhibitory hormones
37. Cholecystokinin in the control of gastric acid secretion in man
38. Suppression of gastrin release and gastric secretion by gastric inhibitory polypeptide (GIP) and vasoactive intestinal polypeptide (VIP)
39. Neurotensin inhibits meal-stimulated gastric acid secretion in man
40. Peptide YY: a physiologic role in the regulation of gastric secretion
41. Somatostatin as a mediator of the effect of neurotensin on pentagastrin-stimulated acid secretion in man
42. Inhibition of gastrin release by gastric inhibitory peptide mediated by somatostatin.
43. Inhibition of gastrin release by secretin is mediated by somatostatin in cultured rat antral mucosa
44. Effect of cholecystokinin and secretin on somatostatin release from cultured antral cells
45. Release of somatostatin immunoreactivity from human antral D cells in culture
46. Effects of monoclonal antibodies to somatostatin on somatostatin-induced and intestinal fat-induced inhibition of gastric acid secretion in the rat
47. Cholecystokinin inhibits gastric acid secretion through type “A” cholecystokinin receptors and somatostatin in rats
48. Effect of glucagon, secretin, and vasoactive intestinal peptide on gastric somatostatin and gastrin release from isolated perfused rat stomach
49. Functional responsiveness of an isolated and enriched fraction of rodent gastrin cells
50. Divergent effects of bombesin and bethanechol on stimulated gastric secretion in duodenal ulcer and in normal men
51. Helicobacter pylori infection induces a decrease in immunoreactive somatostatin concentrations of human stomach
52. Effect of Helicobacter pylori on gastric somatostatin in duodenal ulcer disease
53. Gastrin and somatostatin in Helicobacter pylori infected antral mucosa
54. Effect of Helicobacter pylori eradication on antral gastrin- and somatostatin-immunoreactive cell density and gastrin and somatostatin concentrations